Get the Stockscreener App
0.00
100.00%
-0.0322
Gritstone Bio Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
See More
Previous Close:
$0.0322
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.80M
Revenue:
$1.33M
Net Income/Loss:
$-138.49M
P/E Ratio:
0.00
EPS:
-1.2
Net Cash Flow:
$-126.22M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.10
Gritstone Bio Inc Stock (GRTS) Company Profile
Name
Gritstone Bio Inc
Sector
Industry
Phone
(510) 871-6100
Address
5959 HORTON STREET, SUITE 300, EMERYVILLE, CA
Compare GRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRTS
Gritstone Bio Inc
|
0.00 | 3.80M | 1.33M | -138.49M | -126.22M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.43 | 125.43B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.00 | 76.60B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
667.86 | 39.57B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.81 | 35.33B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.44 | 28.08B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gritstone Bio Inc Stock (GRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-23 | Initiated | Evercore ISI | Outperform |
| Mar-28-23 | Initiated | B. Riley Securities | Buy |
| Oct-31-22 | Initiated | Piper Sandler | Overweight |
| Aug-22-22 | Downgrade | Goldman | Neutral → Sell |
| Dec-15-21 | Resumed | Goldman | Neutral |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Jan-20-21 | Downgrade | Robert W. Baird | Outperform → Underperform |
| Jul-26-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | Raymond James | Outperform |
| Mar-07-19 | Initiated | H.C. Wainwright | Buy |
| Oct-23-18 | Initiated | BTIG Research | Buy |
| Oct-23-18 | Initiated | Goldman | Neutral |
View All
Gritstone Bio Inc Stock (GRTS) Latest News
GRITSTONE BIO, INC. (NASDAQ: GRTS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Gritstone bio, Inc. Investors of Upcoming Deadline - ACCESS Newswire
GRTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Gritstone bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Gritstone (GRTS) Plummets 58% in a Week: Here's Why - MSN
Gritstone bio completes asset sale amid bankruptcy - Investing.com India
Gritstone bio completes asset sale amid bankruptcy By Investing.com - Investing.com Australia
Seattle Project Corp agreed to acquire Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q) for $21.2 million. - Marketscreener.com
Seattle Project Corp completed the acquisition of Substantially all of the assets of Gritstone bio, Inc. from Gritstone bio, Inc. (OTCPK:GRTS.Q). - Marketscreener.com
Leader of failed biotech urges others to hire colleagues - The Business Journals
Gritstone Bio, Inc. Announces Resignation of Executives - Marketscreener.com
Gritstone Bio, Inc. Announces CEO Changes - Marketscreener.com
Gritstone bio Completes Asset Sale Amid Bankruptcy - TipRanks
GRTS Investors Have the Opportunity to Lead Gritstone bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Gritstone bio CFO sells $180 in common stock - Investing.com India
Gritstone bio CFO sells $180 in common stock By Investing.com - Investing.com Australia
Gritstone bio assets auctioned for $21.25 million By Investing.com - Investing.com South Africa
Gritstone bio assets auctioned for $21.25 million - Investing.com
Gritstone Bio sets sale of assets through Bankruptcy Court - The Business Journals
Gritstone Bio Files for Bankruptcy and Auctions Assets - TipRanks
B. Riley Securities Downgrades Gritstone bio (GRTS) - MSN
Gritstone bio reports October financials amid Chapter 11 - Investing.com India
Gritstone bio reports October financials amid Chapter 11 By Investing.com - Investing.com South Africa
Gritstone bio Files for Chapter 11 Bankruptcy - TipRanks
Gritstone bio (GRTSQ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - MSN
Bidding Procedure Approved for Gritstone bio, Inc. - Marketscreener.com
Final DIP Financing Approved for Gritstone bio, Inc. - Marketscreener.com
Gritstone bio : Bankruptcy Form 8 K - Marketscreener.com
Gritstone Bio Can Tap $25M New DIP As It Works Toward Sale - Law360
Gritstone bio Announces Strengthening of Maturing Phase 2 PFS Data for GRANITE Study and Provides Business Update - The Manila Times
Gritstone bio Announces Strengthening of Maturing Phase 2 - GlobeNewswire
GRTSQGRITSTONE BIO INC Latest Stock News & Market Updates - StockTitan
The Story Behind Vaccine Maker Gritstone's Ch. 11 - Law360
Meet The Attys Behind Biotech Co. Gritstone's Ch. 11 - Law360
Metastatic Colorectal Cancer Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics - Barchart
Volatility Of Gritstone Bio Inc (GRTS) Reaches 28.56%: Make Sure To Keep Your Seat Tight! - Stocks Register
GRTS stock plunges to 52-week low of $0.05 amid market challenges - Investing.com
GRTS stock plunges to 52-week low of $0.05 amid market challenges By Investing.com - Investing.com South Africa
Gritstone Bio Files for Bankruptcy Despite Securing Government Vaccine Contract - substack.com
Gritstone bio announces layoffs and Nasdaq delisting By Investing.com - Investing.com Australia
Gritstone bio announces layoffs and Nasdaq delisting - Investing.com
Gritstone bio files for Chapter 11 bankruptcy protection, shares tumble - MSN
GRTS’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Gritstone Bio Inc Stock (GRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):